onfekafusp alfa

Ligand id: 9757

Name: onfekafusp alfa

Compound class Antibody
International Nonproprietary Names
INN number INN
10653 onfekafusp alfa
Onfekafusp alfa (Fibromun; L19-TNF) is a trimeric homodimer that forms from engineered peptides for the L19 antibody in scFv format fused to human TNF [1]. LIke bifikafusp alfa, Fibromun targets the TNF to the tumour microenvironment via L19 binding to the angiogenesis-associated isoform of fibronectin (specifically the extradomain B or EDB). Fibromun is being investigated as an immuno-oncology therapeutic. It is one of a growing number of so-called 'immunocytokines' entering clinical development.
Database Links
GtoPdb PubChem SID 354702230
Search PubMed clinical trials onfekafusp alfa
Search PubMed titles onfekafusp alfa
Search PubMed titles/abstracts onfekafusp alfa